You are here: Industry Insights > Market News > Zimbabwe gets 2 million Sinovac doses to boost COVID-19 vaccination

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Zimbabwe gets 2 million Sinovac doses to boost COVID-19 vaccination

firstwordpharmaJuly 09, 2021

Tag: Zimbabwe , COVID-19 , vaccination

Favorites

Zimbabwe received 2 million COVID-19 vaccines from China’s Sinovac on Thursday, as reported in Sharenet.

The nation has only registered vaccines from China, India and Russia.

Zimbabwe gets 2 million Sinovac doses to boost COVID-19 vaccination

The delivery took Zimbabwe’s total number of vaccines to 4.2 million, after another consignment of 500,000 doses arrived from China last week.

John Mangwiro, deputy minister of health, said by the end of July, Zimbabwe would have received another 3.5 million doses. The country plans to purchase 1.5 million vaccines monthly from August.

Previous:PurMinds Completes Initial Strategic Equity Investment in Israeli Psychedelic Drug Company IMIO Life

Next:Two-dose COVID-19 vaccine response works against delta variant, researchers find

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Zimbabwe gets 2 million Sinovac doses to boost COVID-19 vaccination | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

Zimbabwe gets 2 million Sinovac doses to boost COVID-19 vaccination

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may like
More>>

Zimbabwe gets 2 million Sinovac doses to boost COVID-19 vaccination

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>